Figure 2From: Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis Meta-analysis examining postoperative radiotherapy and surgery compared to surgery alone: mortality at one year. Overall risk ratio = 1.23 (95% CI, 0.95 to 1.59; p = 0.11)Back to article page